13F GuideFiling Basics
What is SEC Form 13F? Ultimate Guide to Institutional Equity Filings
Learn how SEC Form 13F filings work, the $100M threshold, 45-day reporting lag, and how to track top hedge fund holdings.
AlphaSMO Research GuideRead Guide
CIK: 0001582384
Total reported value
$228.5M
$228.5M
8 檔
79.7%
The Q1 2025 SEC filing reveals that Wildcat Capital Management, LLC held a total portfolio value of $228.5M, covering 8 public equity positions.
In Q1 2025, Wildcat Capital Management, LLC adopted a defensive or profit-taking posture, trimming 2 positions and completely liquidating 17 holdings to manage risk exposure.
| # | Ticker | Issuer | Asset Subclass | Weight | Weight Change | Shares Change | 4Q Trend |
|---|---|---|---|---|---|---|---|
| 1 | ULCC | Frontier Group Holdings Inc | Stock-Other | 64.99% | +3.84% | — | |
| 2 | RLX | Rlx Technology Inc-adr | Stock-Other | 18.11% | — | — | |
| 3 | TIC | Tic Solutions Inc | Stock-Other | 8.90% | — | — | |
| 4 | URGN | UroGen Pharma Ltd. | Stock-Other | 2.93% | — | — | |
| 5 | ALLO | Allogene Therapeutics Inc | Stock-Other | 2.28% | -4.05% | — | |
| 6 | 260 | Centessa Pharmaceuticals-adr | Stock-Other | 2.16% | — | — | |
| 7 | KRON1USD | Kronos Bio Inc | Stock-Other | 0.57% | — | — | |
| 8 | ✓ | Stock-Other | 0.07% | — | — |
| # | Ticker | Issuer | Weight Change | Shares Change | Action |
|---|---|---|---|---|---|
| 1 | RLX | Rlx Technology Inc-adr | +17.3% | — | Add |
| 2 | URGN | UroGen Pharma Ltd. | +2% | — | Trim |
| 3 | ALLO | Allogene Therapeutics Inc | -2.8% | — | Add |
| 4 | KRON1USD | Kronos Bio Inc | -3.3% | — | Trim |
| 5 | ✓ | Skillz Inc | — | EXIT | Sold out |
| 6 | ULCC | Frontier Group Holdings Inc | — | NEW | New buy |
| 7 | CSGP | Costar Group Inc | — | EXIT | Sold out |
| 8 | GSHD | Goosehead Insurance Inc -a | — | EXIT | Sold out |
| 9 | META | Meta Platforms Inc-class A | — | EXIT | Sold out |
| 10 | LBRDK | Liberty Broadband-c | — | EXIT | Sold out |
| 11 | BKNG | Booking Holdings Inc | — | EXIT | Sold out |
| 12 | TMUS | T-mobile US Inc | — | EXIT | Sold out |
| 13 | PLNT | Planet Fitness Inc - Cl A | — | EXIT | Sold out |
| 14 | ✓ | Datto Hldg CORP | — | EXIT | Sold out |
| 15 | TIC | Tic Solutions Inc | — | NEW | New buy |
| 16 | GPN | Global Payments Inc | — | EXIT | Sold out |
| 17 | SBR | Sabine Royalty Trust | — | EXIT | Sold out |
| 18 | ACEL | Accel Entertainment Inc | — | EXIT | Sold out |
| 19 | CNSLEUR | Consolidated Communications | — | EXIT | Sold out |
| 20 | ✓ | Playa Hotels & Resorts NV | — | EXIT | Sold out |
| 21 | ✓ | Holicity Inc | — | EXIT | Sold out |
| 22 | 260 | Centessa Pharmaceuticals-adr | — | NEW | New buy |
| 23 | OYST | Oyster Point Pharma Inc | — | EXIT | Sold out |
| 24 | LYFT | Lyft Inc-a | — | EXIT | Sold out |
| 25 | ✓ | — | NEW | New buy |
According to official SEC Form 13F filings, Wildcat Capital Management, LLC reported a total U.S. public equity portfolio value of $228.5M across 8 disclosed positions in Q1 2025.
Expert Analysis & Guides for Tracking Wall Street Smart Money Movements
Learn how SEC Form 13F filings work, the $100M threshold, 45-day reporting lag, and how to track top hedge fund holdings.
In terms of portfolio concentration, the top 5 core holdings (including ULCC, RLX, TIC) accounted for 79.7% of total reported equity market value during Q1 2025.
Top New Position Initiated
ULCC
市值: $121.8M
Top Position Liquidated / Trimmed
SKILLZ INC
前期市值: $461.9M
During Q1 2025, Wildcat Capital Management, LLC's top holdings by market value included ULCC (65.0%)、RLX (18.1%)、TIC (8.9%). The largest single position, ULCC, represented 65.0% of total portfolio value.
In Q1 2025, Wildcat Capital Management, LLC made 25 total portfolio adjustments, initiating 4 new buys, adding to 2 positions, trimming 2 holdings, and fully liquidating 17 stocks.
All holding records on this page are fetched directly from the U.S. Securities and Exchange Commission (SEC) EDGAR system (Form 13F-HR). AlphaSMO parses CUSIP identifiers and formats data into Schema.org-compliant datasets.
Understand SEC Form 4 insider disclosures for corporate officers, directors, and 10% owners to track executive transactions.
Understand Rule 144 restricted stock sale notices to spot planned insider liquidations before market sell pressure arrives.
Explore the 5% beneficial ownership threshold, 13D vs 13G filing differences, and recent SEC accelerated deadline rules.
Best practices for analyzing 13F quarterly changes without getting misled by stock splits, options, or market valuation drift.
Learn how AlphaSMO's flagship signal detects high-conviction stocks where 13F hedge funds and corporate insiders buy at the same time.